Since the K18-hACE2 mouse model recapitulates the outcome of severe COVID-19 in humans, efficacy testing of SARS-CoV-2 candidate vaccines in the K18hACE2 SARS-CoV-2 infection model is of substantial value (32, 42). This evidence concerns the gene KRT18 and COVID-19.